ASP-9521

N/A

Report date: 2022/07/04 19:38:02

NME

Base Information

Drug NameASP-9521

Drug Alias NameASP-9521

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionAldo-keto-reductase family 1 member C3 inhibitors

TargetsAldo-keto-reductase family 1 member C3

Therapy Area/IndicationsProstatic Neoplasms, Castration-Resistant

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryBelgiumUnited KingdomFrance

CombinationsNo

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAstellas Pharma Inc

China Registration ClassN/A

Active CompaniesN/A

Active IndicationsN/A

Inactive IndicationsProstatic Neoplasms, Castration-Resistant

ATC CodeN/A